Abstract:Lewy pathology, consisting of Lewy bodies and Lewy neurites, is the pathological hallmark of synucleinopathies such as Parkinson's disease and dementia with Lewy bodies, but it is generally thought to represent late-stage pathological changes. In contrast, alpha-synuclein oligomers are regarded as early-stage pathology, likely involved in disease progression and cellular toxicity. Oligomers, however, are not detected by standard immunohistochemistry but require specific detection techniques such as the proximity ligation assay (PLA). Here, we describe the MJF-14 PLA, a new PLA towards aggregated alpha-synuclein with unprecedented specificity, attained by the utilization of aggregate conformation-specific alpha-synuclein antibody MJFR-14-6-4-2 (hereafter MJF-14). Signal in the assay directly correlates with alpha-synuclein aggregation in SH-SY5Y cells, as treatment with aggregation inhibitor ASI1D significantly lowers PLA signal. In human cortical neurons, MJF-14 PLA detects pre-formed fibril-induced aggregation, especially prominent when using stealth PFFs invisible to the MJF-14 antibody. Co-labelling of MJF-14 PLA and pS129-alpha-synuclein immunofluorescence in post-mortem dementia with Lewy bodies cases showed that while the MJF-14 PLA reveals extensive non-inclusion pathology, it is not sensitive towards Lewy bodies. In Parkinson's disease brain, direct comparison of PLA and IHC with the MJF-14 antibody, combined with machine learning-based quantification, showed striking alpha-synuclein pathology preceding the formation of conventional Lewy pathology. The majority of the PLA-revealed non-inclusion pathology was found in the neuropil, including some clearly located in the presynaptic terminals. With this work, we introduce an improved alpha-synuclein aggregate PLA to uncover abundant non-inclusion pathology, which deserves future validation with multiple brain bank resources and in different synucleinopathies.

Sensitive detection of aggregated prion protein via proximity ligation

Early detection of prion protein aggregation with a fluorescent pentameric oligothiophene probe using spectral confocal microscopy

Preparations of Specific Antibodies Against PrP N-terminal or C-terminal Peptides and Preliminary Study on Establishment of ELISA Diagnostic Method

Sensitive detection of small molecules by competitive immunomagnetic-proximity ligation assay.

Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA

Detection of prion protein particles in blood plasma of scrapie infected sheep

Generation and Identification of Phage Engineering Antibodies Library Against Hamster Prion Protein

Quick and Sensitive Detection of Prion Disease-Associated Isoform (prpsc) Using a Novel Gold Surface/PrPSc/Gold Nanoparticles Sandwich SPR Detection Assay

MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity

Generation of Genetic Engineering Monoclonal Antibodies Against Prion Protein

Establishment of A Stable Prpsc Panel from Brain Tissues of Experimental Hamsters with Scrapie Strain 263K

Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity

Sensitive detection of pathological seeds of α-synuclein, tau and prion protein on solid surfaces

Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods

Human Anti-prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity

Regenerable and Simultaneous Surface Plasmon Resonance Detection of Aβ(1−40) and Aβ(1−42) Peptides in Cerebrospinal Fluids with Signal Amplification by Streptavidin Conjugated to an N-Terminus-Specific Antibody

The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases

Metal-enhanced Fluorescence of Nano-Core–shell Structure Used for Sensitive Detection of Prion Protein with a Dual-Aptamer Strategy

Specific Detection of Endogenous S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay

Single‐molecule two‐color coincidence detection of unlabeled alpha‐synuclein aggregates

Detection of G Protein‐Coupled Receptor Complexes in Postmortem Human Brain by Proximity Ligation Assay